Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Leaves Pfizer’s Efficacy Data Out Of Under 5 EUA Due To ‘Data Maturity,’ Lack of ‘Confidence’
Jun 17 2022
•
By
Sarah Karlin-Smith
FDA authorized both Pfizer’s and Moderna’s COVID-19 vaccines for infants, toddlers and preschoolers on 17 June. • Source: Shutterstock
More from Vaccines
More from Pink Sheet